Pages that link to "Q73292505"
Jump to navigation
Jump to search
The following pages link to Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis (Q73292505):
Displaying 50 items.
- CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells (Q24291469) (← links)
- Apoptosis: targets in pancreatic cancer (Q24800170) (← links)
- The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice (Q24811656) (← links)
- Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity (Q26797280) (← links)
- Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) (Q26859211) (← links)
- Getting TRAIL back on track for cancer therapy (Q27027460) (← links)
- The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines (Q28213806) (← links)
- Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation (Q28394059) (← links)
- Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to TRAIL-induced apoptosis (Q28729017) (← links)
- Natural Innate and Adaptive Immunity to Cancer (Q29620313) (← links)
- Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family (Q30971455) (← links)
- Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies. (Q33208795) (← links)
- Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model (Q33560683) (← links)
- Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis (Q33636816) (← links)
- PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy (Q33731141) (← links)
- Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors (Q33799792) (← links)
- HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species (Q33869186) (← links)
- New insights into apoptosis signaling by Apo2L/TRAIL. (Q34022690) (← links)
- BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells (Q34168023) (← links)
- Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL (Q34285051) (← links)
- Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax. (Q34488880) (← links)
- Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK (Q34568521) (← links)
- Immune surveillance of tumors (Q34579196) (← links)
- Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress (Q34639429) (← links)
- Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus (Q34656877) (← links)
- A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance (Q34956163) (← links)
- Regulators of apoptosis as anticancer targets (Q35038784) (← links)
- High cell surface death receptor expression determines type I versus type II signaling (Q35371553) (← links)
- Targeting AML through DR4 with a novel variant of rhTRAIL (Q35377418) (← links)
- Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus (EBV ) B cell lymphomas (Q35423739) (← links)
- Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine (Q35600313) (← links)
- Fas death receptor signalling: roles of Bid and XIAP. (Q35657414) (← links)
- Modulation of TRAIL signaling complex. (Q35756863) (← links)
- Modulation of TRAIL signaling for cancer therapy (Q35756898) (← links)
- TRAIL and chemotherapeutic drugs in cancer therapy (Q35756909) (← links)
- Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy. (Q35756912) (← links)
- TRAIL and malignant glioma. (Q35756919) (← links)
- Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors (Q35756929) (← links)
- Mechanisms of resistance to TRAIL-induced apoptosis in cancer (Q35954258) (← links)
- Resistance to TRAIL is mediated by DARPP-32 in gastric cancer (Q36101164) (← links)
- DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer (Q36215003) (← links)
- Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy (Q36263997) (← links)
- Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. (Q36561621) (← links)
- Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis (Q36628057) (← links)
- Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy (Q36782324) (← links)
- Apoptotic pathways in pancreatic ductal adenocarcinoma (Q36835642) (← links)
- Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Prostate Cancer Cells after Treatment with Xanthohumol-A Natural Compound Present in Humulus lupulus L. (Q37050555) (← links)
- Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways (Q37061991) (← links)
- Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy (Q37071019) (← links)
- Therapeutic applications of TRAIL receptor agonists in cancer and beyond (Q37114025) (← links)